We are live on
!
Find out more
Biogen
BIIB
BIIB
1,102 hedge funds and large institutions have $45B invested in Biogen in 2019 Q4 according to their latest regulatory filings, with 204 funds opening new positions, 272 increasing their positions, 470 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
191% more first-time investments, than exits
New positions opened: 204 | Existing positions closed: 70
82% more funds holding in top 10
Funds holding in top 10: 17 → 31 (+14)
21% more capital invested
Capital invested by funds: $37.1B → $45B (+$7.88B)
12% more funds holding
Funds holding: 988 → 1,102 (+114)
2.64% less ownership
Funds ownership: 86.84% → 84.2% (-2.6%)
30% less call options, than puts
Call options by funds: $1.27B | Put options by funds: $1.82B
42% less repeat investments, than reductions
Existing positions increased: 272 | Existing positions reduced: 470
Holders
1,102
Holders Change
+114
Holders Change %
+11.54%
% of All Funds
21.71%
Holding in Top 10
31
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+82.35%
% of All Funds
0.61%
New
204
Increased
272
Reduced
470
Closed
70
Calls
$1.27B
Puts
$1.82B
Net Calls
-$553M
Net Calls Change
-$242M
Top Buyers
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$492M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$395M |
| 3 |
ClearBridge Investments
New York
|
-$304M |
| 4 |
D.E. Shaw & Co
New York
|
-$301M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$295M |